Discovery of Potential New Gene Variants and Inflammatory Cytokine Associations with Fibromyalgia Syndrome by Whole Exome Sequencing

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Feng, Jinong ^a   Zhang, Zhifang ^a   Wu, Xiwei ^a   Mao, Allen ^a   Chang, Frances ^a   Deng, Xutao ^a   Gao, Harry ^a   Ouyang, Ching ^a   Dery, Kenneth J ^a   Le, Keith ^a   Longmate, Jeffrey ^a   Marek, Claudia ^b   St Amand, R Paul ^b   Krontiris, Theodore G ^a   Shively, John E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b RP St Amand MD Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; ZINC FINGER PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; EXOME; FEMALE; FIBROMYALGIA; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN DENATURATION; SCHOOL CHILD; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CXCL10; CHILD; CYTOKINES; EXOME; FEMALE; FIBROMYALGIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MUTATION; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNDROME; YOUNG ADULT;

EID: 84878877206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065033     Document Type: Article

References (17)

1. Wolfe F, Cathey MA, (1990) Assessment of functional ability in patients with fibromyalgia. Arch Intern Med 150: 460.
2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L, (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19-28.
3. Buskila D, Neumann L, Sibirski D, Shvartzman P, (1997) Awareness of diagnostic and clinical features of fibromyalgia among family physicians. Fam Pract 14: 238-241.
4. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, et al. (2004) Family study of fibromyalgia. Arthritis Rheum 50: 944-952.
5. Kato K, Sullivan PF, Evengard B, Pedersen NL, (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166: 1649-1654.
6. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, et al. (1999) The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 6: 433-439.
7. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, (2001) Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 21: 58-61.
8. Buskila D, Cohen H, Neumann L, Ebstein RP, (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9: 730-731.
9. Buskila D, Sarzi-Puttini P, Ablin JN, (2007) The genetics of fibromyalgia syndrome. Pharmacogenomics 8: 67-74.
10. Smith SB, Maixner DW, Fillingim RB, Slade G, Gracely RH, et al. (2012) Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis and rheumatism 64: 584-593.
11. Berkun Y, Eisenstein E, Ben-Chetrit E (2012) FMF- clinical features, new treatments and the role of genetic modifiers: a critical digest of the 2010-2012 literature. Clinical and experimental rheumatology.
12. Romano TJ, (1988) Coexistence of irritable bowel syndrome and fibromyalgia. The West Virginia medical journal 84: 16-18.
13. Sperber AD, Akiva S, Leshno M, Halpern Z, Buskila D, (2011) Validation of New Symptom-Based Fibromyalgia Criteria for Irritable Bowel Syndrome Co-morbidity Studies. Journal of neurogastroenterology and motility 17: 67-72.
14. Feng J, Zhang Z, Li W, Shen X, Song W, et al. (2009) Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. PLoS One 4: e8480.
15. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-172.
16. Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, et al. (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233: 1171-1180.
17. Spielman RS, McGinnis RE, Ewens WJ, (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516.